One target, different effects: a comparison of distinct therapeutic antibodies against the same targets

Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis

(2014) P. V. Beum et al.   JOURNAL OF IMMUNOLOGY

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

(2014) David J. Shealy et al.   mAbs

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

(2011) R. Ghosh et al.   CANCER RESEARCH

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

(2011) S. I. Rudnick et al.   CANCER RESEARCH

Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis

(2011) ROBERT LAUNOIS et al.   JOURNAL OF RHEUMATOLOGY

Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations

(2011) Jeeyun Lee et al.   JNCI-Journal of the National Cancer Institute

Bispecific Antibodies for Cancer Immunotherapy

(2010) Dafne Müller et al.   BIODRUGS

Optimizing Therapeutic Antibody Function

(2010) Etsuji Kaneko et al.   BIODRUGS

Current perspectives on therapeutic antibodies

(2010) Soomin Yoon et al.   BIOTECHNOLOGY AND BIOPROCESS ENGINEERING

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

(2010) Melarkode S. Ramakrishnan et al.   mAbs

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

(2010) E F Dunn et al.   ONCOGENE

CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies

(2010) Stephen A. Beers et al.   SEMINARS IN HEMATOLOGY

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

(2009) Teemu T. Junttila et al.   CANCER CELL

Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope

(2009) Susumu Uchiyama et al.   CANCER SCIENCE

Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases

(2009) Nádia Emi Aikawa et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Certolizumab pegol for the management of Crohn's disease in adults

(2009) Anastasia Rivkin   CLINICAL THERAPEUTICS

ErbB receptors and signaling pathways in cancer

(2009) Nancy E Hynes et al.   CURRENT OPINION IN CELL BIOLOGY

Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway

(2009) Debora Dummer Meira et al.   EUROPEAN JOURNAL OF CANCER

Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis

(2009) Roger Palframan et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

(2009) Tanja Schneider-Merck et al.   JOURNAL OF IMMUNOLOGY

Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2 ) with antibodies

(2009) Johan Rockberg et al.   Molecular Oncology

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

(2008) Alberto Alonso-Ruiz et al.   BMC MUSCULOSKELETAL DISORDERS

Antibody-Drug Conjugates for Cancer Therapy

(2008) Paul J. Carter et al.   CANCER JOURNAL

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR

(2008) Volker Heinemann et al.   CANCER TREATMENT REVIEWS

Interaction of antibodies with ErbB receptor extracellular regions

(2008) Karl R. Schmitz et al.   EXPERIMENTAL CELL RESEARCH

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer

(2008) Antonino Musolino et al.   JOURNAL OF CLINICAL ONCOLOGY

Epitope mapping of antibodies using bacterial surface display

(2008) Johan Rockberg et al.   NATURE METHODS

Synergy Between Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract

(2008) R. L. Mahtani et al.   ONCOLOGIST